Global burden of liver disease: 2023 update

H Devarbhavi, SK Asrani, JP Arab, YA Nartey… - Journal of …, 2023 - Elsevier
Liver disease accounts for two million deaths annually and is responsible for 4% of all
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment

JM Llovet, CE Willoughby, AG Singal… - Nature reviews …, 2023 - nature.com
Nonalcoholic fatty liver disease (NAFLD), including its more severe manifestation,
nonalcoholic steatohepatitis (NASH), has a global prevalence of 20–25% and is a major …

[HTML][HTML] Advances in dendritic cell vaccination therapy of cancer

S Najafi, K Mortezaee - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Traditionally, vaccines have helped eradication of several infectious diseases and also
saved millions of lives in the human history. Those prophylactic vaccines have acted through …

[HTML][HTML] Recent advances in protective vaccines against hepatitis viruses: A narrative review

A Elbahrawy, H Atalla, M Alboraie, A Alwassief… - Viruses, 2023 - mdpi.com
Vaccination has been confirmed to be the safest and, sometimes, the only tool of defense
against threats from infectious diseases. The successful history of vaccination is evident in …

[HTML][HTML] Prevalence of human immunodeficiency virus, syphilis, and hepatitis B and C virus infections in pregnant women: a systematic review and meta-analysis

S Wu, J Wang, Q Guo, H Lan, Y Sun, M Ren… - Clinical Microbiology …, 2023 - Elsevier
Abstract Background At the 74th World Health Assembly, the WHO issued a strategy for the
prevention and control of several major infectious diseases. To achieve the WHO-initiated …

[HTML][HTML] Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma

N Gull, F Arshad, GA Naikoo, IU Hassan… - Journal of …, 2023 - Springer
Purpose Among all forms of cancers, hepatocellular carcinoma (HCC) is the fifth most
common cancer worldwide. There are several treatment options for HCC ranging from loco …

[HTML][HTML] Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective

TH Su, CH Wu, TH Liu, CM Ho… - Clinical and Molecular …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fourth most common cancer and the second leading
cause of cancer-related death in Taiwan. The Taiwan Liver Cancer Association and the …

[HTML][HTML] Stationary trend in elevated serum alpha-fetoprotein level in hepatocellular carcinoma patients

YH Yen, KM Kee, WF Li, YW Liu, CC Wang, TH Hu… - Cancers, 2023 - mdpi.com
Simple Summary In this study, we demonstrated that overall 51.2% of patients with
hepatocellular carcinoma (HCC) had elevated alpha-fetoprotein (AFP) levels. The …

[HTML][HTML] Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population …

L An, R Zheng, S Zhang, R Chen, S Wang… - … Surgery and Nutrition, 2023 - ncbi.nlm.nih.gov
Background Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC)
are the most common subtypes of primary liver cancer, but nationwide incidence of both liver …

[HTML][HTML] Molecular engineering tools for the development of vaccines against infectious diseases: current status and future directions

W Xue, T Li, Y Gu, S Li, N Xia - Expert Review of Vaccines, 2023 - Taylor & Francis
Introduction The escalating global changes have fostered conditions for the expansion and
transmission of diverse biological factors, leading to the rise of emerging and reemerging …